top of page

Selling Software & Technology

Software & Technology

The healthcare software and technology sector is booming, driven by the need for efficiency, data management, and telemedicine. Companies in this space are highly sought after by investors and larger tech firms due to their potential for scalability and innovation.

Frequently Asked Questions

How are Software and Technology Companies are Valued?

There are number of valuation methods that can be used in determining the valuation of your company. The most common is based on the top line revenue, bottom line adjusted EBITDA and a multiplier based on market conditions. For Software and Technology companies, we also see valuation based on its revenue if the company is not yet profitable but it has a good monetization model and is on the verge of profitability. To get a free and confidential valuation of your company, fill out the form, and one our managing directors will be able to provide you a current market valuation for your company.

How long will it take for me to sell my software and technology to a potential buyer or an investor?

It is generally a 4-6 month process from the time we receive all the information we need from you to go to market.

Who are the typical buyers for healthcare software and tech companies?

Larger technology firms, private equity firms, and healthcare providers.

What are the common challenges when selling a software or tech company?

Ensuring intellectual property protection and maintaining customer relationships during the transition can be challenging.

What factors determine the value of a healthcare software or technology company?

Valuation is influenced by the uniqueness of the software, customer base, and revenue growth.

Active Listings

Medical Device Manufacturer with FDA Approval and Medicare and Private Insurance Reimbursements

State:

Not Disclosed

Category:

Software & Technology

Revenue

$7,000,000

Asking Price:

-

Listing Code:

XYMF1W

Highly Scalable Specialty Medical Software Company with Recurring Revenue

State:

Not Disclosed

Category:

Software & Technology

Revenue

$500,000

Asking Price:

-

Listing Code:

XYSW1U

$1.2 Million ARR Digital Therapeutics Company Seeking Strategic/Capital Partner

State:

Not Disclosed

Category:

Software & Technology

Revenue

$1,200,000

Asking Price:

$6,000,000

Listing Code:

XYTECH1E

Highly Scalable, Turnkey Remote Therapy Monitoring SaaS Platform

State:

Not Disclosed

Category:

Software & Technology

Revenue

-

Asking Price:

-

Listing Code:

XYTECH1D

AI-Powered Mental Health Platform Driving Measurable Outcomes

State:

Not Disclosed

Category:

Software & Technology

Revenue

-

Asking Price:

-

Listing Code:

XYSW2C

$4.2 Million Revenue MedTech Software Digital Video Imaging and Integration

State:

Not Disclosed

Category:

Software & Technology

Revenue

$4,200,000

Asking Price:

-

Listing Code:

XYSW1Y

Currently, there are no available listings. We are actively seeking new opportunities for our buyers and investors. Please contact us for more information

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings

About us
 

PRIME exits® is a registered trademark of Nazeri & Company LLC, an independent affiliate of American Healthcare Capital. Nazeri & Company Co., Ltd. (Thailand) operates as a separate and independent entity, providing marketing and content creation services. PRIME exits® is a specialized merger and acquisition advisory firm dedicated to the healthcare industry, supported by a network of over 50 M&A analysts and advisors.

 

Locations

Los Angeles

Las Vegas

Bangkok

Vancouver, BC

Milan, Italy

Contact us

 

1-800- 424-3388 HEAD OFFICE

1-310-625-7889 Jack Eskenazi

1-702-506-3392 Dr. Allen Nazeri 

Valuation Team

Jack@ahcteam.com

Allen@ahcteam.com

Allen@pexits.com

PRIME exits M&A Bio Barcode
bottom of page